Nail fungus: the full therapy pathway

You mostly can't by looking — and neither, honestly, can clinicians, which is why the test exists. Somewhere between a third and half of fungal-looking nails turn out to be psoriasis, footwear trauma, ageing changes or something else entirely, and every one of those ignores antifungal treatment completely. The test is as easy as medicine gets: clippings and debris sent for microscopy and culture, usually via a GP. It's the cheapest item on this whole page and the only one that converts everything after it from gambling to planning.

Because the section is named after the problem, not the solution. The antifungals in those kits — tolnaftate, undecylenic acid — are genuinely effective on skin, but the nail plate is a dense keratin shield they can't meaningfully cross, and no over-the-counter product anywhere holds an approved nail-cure indication. Read the small print and you'll find careful phrasing about 'improving nail appearance' or treating the fungus 'around' the nail. Their honest jobs are the surrounding skin and prevention; the products with actual cure rates start at the prescription counter.

Their reputation runs a couple of decades behind their data. Terbinafine's serious liver risk is real but rare, and it's exactly why the pre-course conversation covers your liver history and medications, with blood tests at your clinician's discretion — the screening is the safety system working, not a warning sign. The side effect people actually quit over is more mundane: taste disturbance, which usually resolves after stopping but can be genuinely unpleasant. Weigh it against the alternative honestly — the tablets are a twelve-week course with the best cure rates on the page; the 'safe' route is often a year of daily lacquer at lower odds.

Quite possibly not — look at the right end of the nail. Treatment doesn't repair damaged plate; it protects new growth, so the wrecked part you're staring at was always going to look wrecked until it grows off the end and gets clipped away. The question that matters: is the nail emerging at the base clear and normal? If yes, you're watching success in slow motion — toenails need nine to eighteen months to fully replace themselves. If the base is growing out infected too, that's a genuine failure signal, and it earns a re-test before any second course.

At the price of the claim being made, no — not on current evidence. The Cochrane review of device treatments found the trial base small and inconsistent, and the regulatory clearances these devices hold are for temporary cosmetic improvement, a much humbler claim than the cure rates the tablets are judged against. That gap between clearance and clinic marketing is where your four figures go. If a clinic can show you culture-confirmed cure rates at twelve months and a plan for failure, listen; if the pitch is 'avoid the toxic pills', you're hearing marketing aimed at a fear the data doesn't support.

Almost certainly from your own feet: athlete's foot is the usual source, and the nail infection is its slow-motion sequel — warm damp shoes, communal showers, pool decks and years of small nail traumas write most origin stories. Transmission to others is possible but lazy; the fungus spreads via shed skin and shared surfaces rather than casual contact. The practical courtesies: no shared towels, clippers or shoes, sandals in the family bathroom if your feet are actively peeling, and treat your athlete's foot promptly — that last one protects your household and your other nine nails simultaneously.

That's a legitimate question with a personal answer. Reasons to treat: it never resolves on its own, it slowly recruits neighbouring nails, thickened plates eventually do hurt in shoes, it's a standing reservoir for athlete's foot, and for anyone with diabetes or circulation trouble the calculus isn't optional — thick nails are a wound risk. Reasons some skip it: slow-growing elderly nails, medication conflicts, or simple indifference to how a toenail looks. What matters is choosing rather than drifting — 'contained, trimmed and monitored' is a real strategy, while 'ignored until it spreads' is just the expensive version of deciding later.

Possibly not. Studies of nails referred as fungal find no fungus in somewhere between a third and half, so a clipping test is the only honest answer.

Thick, yellow, crumbling nails are the classic picture, and they are also produced by psoriasis, years of footwear trauma, ordinary ageing and several rarer conditions. Nothing about the appearance separates them reliably, which is why the single most useful number here is that a large share of nails sent for testing come back with no fungus in them at all. That matters practically rather than academically: every antifungal ever made, from the pharmacy pen to the prescription tablet, does precisely nothing for a nail that is thickened by trauma or psoriasis. Some patterns tilt the odds. A single dramatically different nail is more suspicious than ten identically weathered ones. Infection creeping in from the free edge with debris packed underneath fits; symmetrical thickening on both big toes in a runner does not. But tilting the odds is not the same as knowing, and the clipping costs less than most of the products bought instead of it.

Usually from your own athlete's foot. The skin of the foot is the beachhead and the nail is the fortress, with warm damp shoes supplying everything the fungus needs.

Most toenail infections are the second act of a skin infection. Dermatophytes, the same organisms behind athlete's foot, colonise the webs and soles first, then find their way under the free edge of a nail, where they are protected from almost everything you might apply. What allows all of it is the environment: enclosed shoes, warmth, sweat that cannot evaporate, and the small breaches in skin and nail that footwear and sport supply. Communal wet floors, meaning pool surrounds, gym showers, changing rooms and hotel bathrooms, are where the organism is picked up in the first place. Age raises the odds because nails grow more slowly, as do diabetes, poor circulation, immunosuppression and repeated nail trauma. None of that is a hygiene verdict, and the practical takeaway is not guilt but sequence: treating the nail while ignoring the foot is the classic recipe for a cure that does not last.

No. No over-the-counter product is approved to cure infection of the nail plate, and several popular kits contain no antifungal at all.

The aisle labelled fungal nail is largely selling adjacency to a claim it cannot make. Some kits contain monograph antifungals such as tolnaftate or undecylenic acid, which are skin drugs; against the dense keratin of the plate they do not reach the colony underneath. Others contain no antifungal whatever. One widely sold nail renewal product is built on urea, glycerin, lactic acid and propylene glycol, all keratolytics and humectants, and the brand says so on its own product page. What those do is soften and smooth the surface, which improves appearance within days because light reflects more evenly off a less roughened plate. Nothing about the infection has changed. That is worth knowing before spending a year on it, which is the single most common story in this condition and the most avoidable. There is a legitimate role for these products in comfort and containment; cure sits at the prescription tier, and arriving there early with a test in hand beats a year of hopeful painting.

Athlete's foot cream for the skin reservoir, urea for softening thick nails, decent clippers and files, and prevention for the other nine nails. Not a cure.

The shelf has a real job here, and it is not the one the packaging implies. Terbinafine or azole cream applied to the whole foot clears the athlete's foot that feeds the nail and that will reinfect it after any cure, and that is genuinely evidence-backed value for a few pounds. High-strength urea softens and thins diseased plate, which makes thick nails comfortable and gives a prescription topical less wall to cross. Proper clippers and a file manage bulk. Antifungal powder in shoes and sandals for communal floors protect the nails that are still healthy. That is the honest list. What no over-the-counter product does is cure an infected plate, and no such product is approved to claim it. So the sequence that saves money is: get the nail tested, treat the skin and the environment meanwhile, and put the cure budget at the prescription tier rather than into a year of painting.

Months, because nothing visible happens at first, then a sliver of clear nail appears at the base and advances slowly toward a verdict at nine to eighteen months.

Recalibrating the clock is most of what makes this condition bearable. Nothing here works on skincare time, because the damaged nail never heals; it gets replaced, millimetre by millimetre, as new plate grows out from the base. A toenail takes roughly twelve to eighteen months to replace itself entirely, and fingernails around half that. So a perfectly effective treatment produces no visible change for the first two or three months, then a band of normal-looking nail at the cuticle, then a slow tide as the wrecked portion migrates outward and gets clipped away. People abandon working treatment at week six constantly, because at week six there is nothing to see and the drug is working in nail that has not emerged yet. Two things follow. Judge at the base rather than the tip. And take a photograph monthly, because a change of a millimetre a month is invisible to memory and obvious in a sequence.

It strongly inhibits a major drug-metabolising enzyme, so it raises levels of a long list of common medicines, including some statins, sedatives and heart drugs.

Itraconazole blocks cytochrome P450 3A4, the enzyme responsible for clearing a very large share of prescription drugs, so anything metabolised that way accumulates while it is on board. The list is long and includes some statins, where the combination raises the risk of muscle damage; certain benzodiazepines and sedatives; several heart rhythm and blood pressure medicines; some immunosuppressants; certain anticoagulants; and some antipsychotics, migraine drugs and HIV medicines. Its own absorption is also fussy in the other direction, depending on stomach acidity, so antacids and proton pump inhibitors reduce how much you take in. There is one further check specific to this drug: a history of heart failure or reduced heart function matters, and it is worth saying even if unasked. None of this makes itraconazole a bad option, and it is genuinely useful for organisms terbinafine suits less well. It makes the medication reconciliation before prescribing a safety feature rather than paperwork.

One tablet daily for twelve weeks for toenails or six for fingernails, then months of watching clear nail advance while doing nothing further.

The course itself is undramatic: a daily tablet, usually 250mg for an adult, taken for twelve weeks if toenails are involved and six for fingernails. Before starting, expect a medication and liver history and possibly a blood test, at your clinician's discretion. During, the commonest complaints are taste disturbance, stomach upset and occasional rash, none of which most people experience. Then the course ends and nothing appears to have happened, which is the part worth preparing for. The drug binds into keratin and persists in the nail for months after the last dose, working on plate that has not yet emerged, so the verdict lives at the growth line six to twelve months later rather than at week twelve. Two things to do alongside. Treat the athlete's foot on the skin throughout, or the cure meets its own reinfection. And photograph the base monthly, since that advancing clear band is the only measure that means anything.

It is the highest-value purchase on this page. Between a third and half of nails that look fungal are not, and no antifungal helps those at all.

If you spend money on one thing here, spend it on knowing what you are treating. The arithmetic is unusually clear: a large share of nails referred as fungal contain no fungus, so treating on appearance alone means a substantial chance of committing to nine to twelve months of a topical, or twelve weeks of tablets and a liver conversation, aimed at psoriasis, old trauma or age. The test costs less than most of the products people buy instead of it, is painless, and takes seconds to perform. It does two further things beyond confirming. It names the organism, which matters when the first drug fails and someone has to choose the second. And where it is negative, it redirects the whole plan towards the condition you actually have. In systems where the test is free or cheap, there is no argument at all. Where you are paying, it still outperforms almost anything else you could buy with the same money.

Treatment is normally deferred until afterwards. This condition moves so slowly that waiting costs almost nothing, and it is one of medicine's most postponable problems.

Stated plainly: the standard answer in pregnancy is to wait. Oral antifungals are avoided, and even topical courses usually wait, not because a lacquer is known to be dangerous but because a nine-to-twelve-month course started now would run through the pregnancy for no urgent reason. A nail infection changes over years, so a nine-month delay changes essentially nothing about the eventual outcome. Postponement here is the plan rather than a compromise, and it is worth saying out loud so it reads as a considered decision instead of a brush-off. What remains available and useful throughout: treating athlete's foot on the skin with topical antifungal cream, which is generally regarded as compatible with pregnancy; softening and trimming thick nails for comfort; keeping feet dry and shoes rotated; and having the clipping test done, which carries no pregnancy implication and means treatment can start promptly afterwards. Confirm any specific product with whoever is providing your antenatal care.

Usually something benign, but a new, widening or single dark band needs a clinician promptly, because subungual melanoma's classic disguise is a bruise that never grows out.

Most dark lines under nails are not dangerous. Bruising from injury grows out over months, and longitudinal pigmented bands are common and often entirely normal in deeply pigmented skin, frequently affecting several nails. What changes the picture is a specific pattern: a single band that is new, that widens over time, that has irregular colour or edges, or that bleeds pigment onto the skin of the nail fold beside it. That last feature, called Hutchinson's sign, is a recognised warning, though it appears in benign conditions too and is not by itself proof. Amelanotic subungual melanoma, which lacks obvious pigment altogether, accounts for a substantial minority of cases and is one reason a nail that behaves oddly warrants examination even without a dark streak. The action is simple and worth taking seriously: get it looked at rather than treating it as fungus, and do not apply anything to it meanwhile. Photograph it now so change is measurable.

Rotate at least two pairs so each dries fully, pull insoles out overnight, use antifungal powder in the worst offenders, and retire ancient shoes rather than curing into them.

Shoes are a reservoir and a climate, and the habits here undo more cures than pharmacology fails. The single most effective change is rotation: at least two pairs worn alternately, so each has a full day to dry out rather than being pulled on damp every morning. Pull insoles out at night, loosen laces and let boots actually open. Antifungal powder or spray inside gym shoes and work boots reduces the load and helps keep them dry, which is worth doing even though it does nothing to the nail itself. Sandals or breathable shoes in hot weather. And a specific piece of advice people resist: the pair you were wearing when this started, worn daily for years and too good to throw out, is worth retiring rather than putting your feet straight back into after a cure. You do not need to burn your wardrobe, and boiling or freezing shoes is not necessary. Drying, rotating and occasionally replacing does the work.

It can. Recurrence is a lifelong possibility rather than a treatment failure, and the prevention habits are what keep pruning it back.

Even the best-evidenced treatment leaves a meaningful minority needing a second act, and recurrence after a genuine cure is common enough to plan for. Two mechanisms account for it. Relapse, where a residual population that was never fully eliminated re-establishes itself in the same nail. And reinfection, where the organism arrives again from the skin of your own foot, from shoes worn straight back into a cure, or from the same communal floors that supplied it the first time. The second is far more common and far more preventable, which is the useful news. What actually reduces recurrence is unglamorous: treating athlete's foot the week it appears, every time, rather than waiting; rotating and drying shoes; sandals in communal wet spaces permanently; keeping nails trimmed and thinned; and separate disinfected tools. None of that costs much. Watching the base of the nail periodically and acting at the first sign of change is the other half, since early infection is far easier to treat than established.

Entirely, and it is measured rather than assumed. In one survey of confirmed cases, around three-quarters of people reported embarrassment about their nails.

This is the part of the condition people are least likely to mention at an appointment and most likely to feel. It is also well documented: quality-of-life work in onychomycosis consistently finds embarrassment, self-consciousness and avoidance of situations involving bare feet, along with effects on social functioning and mood. In one telephone survey of people with confirmed infection, roughly three-quarters reported embarrassment, alongside high rates of trimming difficulty and pain. So the feeling is a recognised feature of the condition rather than vanity, and it is a legitimate reason to treat if you want to. Two things worth holding. Saying it out loud at an appointment is useful clinical information and makes treatment more likely to be offered rather than deferred. And the practical workarounds are real: covering a nail for a specific occasion is entirely reasonable, and keeping nails trimmed and thinned improves appearance considerably even before any cure arrives.

Get it looked at promptly and apply nothing to it meanwhile. Subungual melanoma's classic disguise is a bruise that never grows out, and early diagnosis matters enormously.

Most dark nail changes are benign, including bruising from injury and the pigmented bands that are common and normal in deeply pigmented skin. The reason this sits among the red flags is the small number that are not, and how often those are treated as something else for months. A dark band that is new, that is widening, that is on a single nail when the others are unaffected, that has irregular colour or edges, or that spreads pigment onto the skin of the nail fold beside it, all warrant examination rather than watchful waiting. So does a dark area with no injury to explain it. Up to a third of subungual melanomas carry little visible pigment at all, so an unexplained nail change that behaves oddly deserves the same attention even without a streak. What to do: book an appointment now rather than at the next convenient moment, photograph it today so change is measurable, and do not apply antifungal or anything else to it in the meantime.

The evidence is thin. Devices are cleared for temporary cosmetic improvement rather than cure, and the main documented risk is financial: four figures against uncertain outcomes.

This is the most heavily marketed tier and the one with the widest gap between advertising and evidence. Regulatory clearance for these devices is generally for temporary increase in clear nail, which is a cosmetic claim rather than a cure claim, and the Cochrane review of topical and device treatments describes the device data as notably limited. That does not mean nothing happens; it means nobody can currently promise you a cure rate. Sessions are multiple, spaced weeks apart, cash-priced, and often sold alongside topicals, which makes attributing any improvement difficult. Two questions expose the quality of a clinic: what is your cure rate confirmed by culture at twelve months, and what happens if it fails. The quality of the answers is the consultation. And be sceptical of the pitch that this avoids the toxic tablets, since that compares a marketing claim against a safety profile most people tolerate uneventfully. Money here does better spent on a test and a course of generic tablets.

Look for a named antifungal and what it claims. If the actives are urea, lactic acid and glycerin, it is a cosmetic softener; if it says appearance, it is not claiming cure.

Two things on the box tell you almost everything. First, the active ingredients. A named antifungal such as tolnaftate, undecylenic acid or amorolfine means the product has antifungal activity, though only amorolfine is designed for the nail plate. Urea, lactic acid, glycerin and propylene glycol are keratolytics and humectants: they soften and smooth, which is genuinely useful for comfort and for helping a real treatment penetrate, and they do not kill anything. Second, the wording of the claim. Improves the appearance of nails, restores nail clarity, or reduces discolouration are cosmetic claims, deliberately phrased to avoid saying cure, because no over-the-counter product is approved to cure infection of the plate. Anything implying eradication without a named antifungal is worth putting back on the shelf. Two more signals. Before-and-after photographs at two days are showing surface optics rather than biology. And prominent tea tree oil usually indicates a cosmetic formula with a marketing story attached.